DK0539590T3 - Plasmid indeholdende DNA, som koder for aminosyresekvensen af TCF-II, en transformeret celle og fremstilling af et fysiolog - Google Patents

Plasmid indeholdende DNA, som koder for aminosyresekvensen af TCF-II, en transformeret celle og fremstilling af et fysiolog

Info

Publication number
DK0539590T3
DK0539590T3 DK91912323T DK91912323T DK0539590T3 DK 0539590 T3 DK0539590 T3 DK 0539590T3 DK 91912323 T DK91912323 T DK 91912323T DK 91912323 T DK91912323 T DK 91912323T DK 0539590 T3 DK0539590 T3 DK 0539590T3
Authority
DK
Denmark
Prior art keywords
tcf
cdna
amino acid
plasmid containing
physiologist
Prior art date
Application number
DK91912323T
Other languages
English (en)
Inventor
Nobuyuki Shima
Kanji Higashio
Masaya Nagao
Fumiko Oogaki
Hiroaki Takaoka
Eisuke Tsuda
Eisuke Maronie Haitsu Tsuda
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of DK0539590T3 publication Critical patent/DK0539590T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91912323T 1990-07-13 1991-07-15 Plasmid indeholdende DNA, som koder for aminosyresekvensen af TCF-II, en transformeret celle og fremstilling af et fysiolog DK0539590T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18585290 1990-07-13
PCT/JP1991/000942 WO1992001053A1 (fr) 1990-07-13 1991-07-15 Plasmide contenant l'adn qui code pour la sequence d'acides amines du facteur tcf-ii, cellules transformees par ce plasmide et production d'une substance physiologiquement active grace a l'utilisation de ce plasmide

Publications (1)

Publication Number Publication Date
DK0539590T3 true DK0539590T3 (da) 1999-10-11

Family

ID=16178009

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91912323T DK0539590T3 (da) 1990-07-13 1991-07-15 Plasmid indeholdende DNA, som koder for aminosyresekvensen af TCF-II, en transformeret celle og fremstilling af et fysiolog

Country Status (10)

Country Link
US (1) US5328836A (da)
EP (1) EP0539590B1 (da)
JP (1) JP2634323B2 (da)
KR (1) KR0153009B1 (da)
AT (1) ATE178354T1 (da)
CA (1) CA2066618C (da)
DE (1) DE69131069T2 (da)
DK (1) DK0539590T3 (da)
ES (1) ES2132087T3 (da)
WO (1) WO1992001053A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5821223A (en) * 1990-09-14 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
ES2143990T3 (es) * 1991-07-26 2000-06-01 Toray Industries Utilizacion de factores de crecimiento de hepatocitos para la fabricacion de un multiplicador de celulas cepa hematopoyeticas.
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
US5316921A (en) * 1992-05-18 1994-05-31 Genentech, Inc. Single-chain hepatocyte growth factor variants
CA2118012A1 (en) * 1992-05-18 1993-11-25 Paul J. Godowski Hepatocyte growth factor variants
AU674871B2 (en) * 1992-07-16 1997-01-16 Atlas Pharmaceuticals Inc. Blood coagulation normalizer containing TCF-II as active ingredient
DK0821969T3 (da) * 1992-07-16 2007-03-26 Daiichi Seiyaku Co Medicinsk sammensætning omfattende TCF-II
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
IT1271088B (it) * 1994-11-24 1997-05-26 Dompe Spa Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
ZA9510982B (en) * 1994-12-27 1996-08-22 Snow Brand Milk Products Co Ltd TCF mutant
KR19980020025A (ko) * 1996-09-05 1998-06-25 김종진 미생물을 이용한 폐수중의 나프탈렌 제거 방법
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
CA2253629A1 (en) * 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent for preventing and/or treating cachexia
KR100562824B1 (ko) 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
AU2005319578A1 (en) * 2004-11-24 2006-06-29 Neopro Labs, Llc Methods and compositions for treating conditions
EP2015765A4 (en) * 2006-03-28 2011-11-23 Neopro Labs Llc METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
WO2008144675A1 (en) 2007-05-17 2008-11-27 Neopro Labs, Llc Crystalline and amorphous forms of peptide
WO2009012472A2 (en) * 2007-07-18 2009-01-22 Neopro Labs, Llc Methods and compositions for treating conditions
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
ES2556711T3 (es) * 2008-04-09 2016-01-19 Viromed Co., Ltd. Formulaciones liofilizadas de ADN para el aumento de la expresión del ADN plasmídico
ES2773305T3 (es) 2013-10-22 2020-07-10 Helixmith Co Ltd Composición para la prevención o tratamiento de la esclerosis lateral amiotrófica que utiliza dos o más isoformas del factor de crecimiento de hepatocitos
JP7212230B2 (ja) 2018-07-19 2023-01-25 ヘリックスミス カンパニー， リミテッド ネイキッドｄｎａ遺伝子療法のための凍結乾燥した薬剤学的組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62171696A (ja) * 1986-01-23 1987-07-28 Sumitomo Chem Co Ltd ヒトエリスロポエチンの製造方法
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
CA2022752C (en) * 1989-08-11 1998-07-07 Naomi Kitamura Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor
JP2777678B2 (ja) * 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法

Also Published As

Publication number Publication date
KR920702417A (ko) 1992-09-04
ES2132087T3 (es) 1999-08-16
US5328836A (en) 1994-07-12
JP2634323B2 (ja) 1997-07-23
DE69131069T2 (de) 1999-07-15
CA2066618C (en) 1998-05-19
DE69131069D1 (de) 1999-05-06
WO1992001053A1 (fr) 1992-01-23
KR0153009B1 (ko) 1998-10-15
CA2066618A1 (en) 1992-01-14
ATE178354T1 (de) 1999-04-15
EP0539590B1 (en) 1999-03-31
EP0539590A4 (da) 1995-05-24
EP0539590A1 (en) 1993-05-05

Similar Documents

Publication Publication Date Title
DK0539590T3 (da) Plasmid indeholdende DNA, som koder for aminosyresekvensen af TCF-II, en transformeret celle og fremstilling af et fysiolog
ES8401777A1 (es) Procedimiento para producir un polipeptido.
MY101887A (en) A novel human physiologically active polypeptide.
DK288183A (da) Fremgangsmaade til fremstilling af et oligonucleotidt terapeutisk middel
DE68905633D1 (de) Markierer der t-zelle aktivierung.
DK491487A (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
DE69227392T2 (de) Serumfreies Medium zur Züchtung von Tierzellen
DE68929134T2 (de) Endothelin-DNA und Verwendung davon
FI843844A0 (fi) Cdna-kloners kodning foer polypeptider med flerlinjig cellvaextfaktoraktivitet och/eller mastcellvaextfaktoraktivitet.
DK619086A (da) Gm-csf-protein, derivater deraf, samt fremstilling og anvendelse af saadanne proteiner
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
DK345286D0 (da) Cdna-kloner, der koder for polypeptider med aktivitet som human granulocyt/makrofag og eosinofil cellevaekstfaktor
WO2001096527A3 (en) Peptides with physiological activity
DK358787D0 (da) Vaekstfaktor, nucleotidsekvens kodende for vaekstfaktoren ekspressionsplasmid omfattende nucleotidsekvensen,vaert indeholdende plasmidet protein fremstillet af vaerten, fremgangsmaade til fremstilling af vaekstfaktoren og farmaceutisk praeparat indeholdendevaekstfaktoren
ATE513900T1 (de) Herstellung und verwendung von humanen cd124 und cd116 positiven tumorzelllinien zur herstellung von allogenen oder semi-allogenen immuntherapeutika
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
DE3787044D1 (de) Transformant einer tierischen zelle, verfahren zur herstellung des transformanten und dessen verwendung zur praeparation eines gewuenschten fremdgenproduktes.
ATE60359T1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
JPS6480298A (en) Production of human proapolipoprotein a-i-like protein
DE60220469D1 (de) Verfahren zur Herstellung von pharmazeutisch aktiver, rekombinanter Urokinase umfassend die Verwendung von Buttersäure oder deren Salze
JPS6437291A (en) Human cytochrome c gene and use thereof
JPS6410983A (en) Artificial tissue and production thereof
IT8519118A1 (it) Procedimento per la produzione di colture di tessuti mixotrofiche e piante resistenti agli erbicidi
JPS646298A (en) Novel physiologically active polypeptide
TH3929A (th) โพลีเพปไทด์ของคนที่ออกฤทธิ์ทางสรีรวิทยาชนิดที่เป็นสารใหม่สารใหม่